EverSource Wealth Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

EverSource Wealth Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.5K	Buy	3,029 +1,469	+94%	+$9.6K	﹤0.01%	2490
2026 Q1	$10.8K	Buy	1,560 +516	+49%	+$3.98K	﹤0.01%	2874
2025 Q4	$9.21K	Sell	1,044 -122	-10%	-$671	﹤0.01%	2842
2025 Q3	$5.82K	Buy	1,166 +1,056	+960%	+$4.89K	﹤0.01%	3092
2025 Q2	$519	Buy	+110	New	+$481	﹤0.01%	3885
2023 Q1	–	Sell	-92	Closed	-$680	–	2544
2022 Q4	$680	Hold	92	–	–	﹤0.01%	2162
2022 Q3	$1K	Buy	+92	New	+$971	﹤0.01%	1918

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EverSource Wealth Advisors's VNDA Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Vanda Pharmaceuticals (VNDA) stake by 94% in Q2 2026, buying an estimated $9.6K and bringing the position to 3,029 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

EverSource Wealth Advisors first reported a position in VNDA in Q3 2022 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

EverSource Wealth Advisors held 3,029 shares of Vanda Pharmaceuticals worth $18.5K as of Q2 2026.
EverSource Wealth Advisors bought 1,469 Vanda Pharmaceuticals shares in Q2 2026, an estimated $9.6K.
Vanda Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2490 holding.
EverSource Wealth Advisors first reported a position in Vanda Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.